RICE HALL JAMES & ASSOCIATES, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,505,995
-31.7%
696,065
-21.5%
0.92%
-23.6%
Q2 2023$21,230,559
+27.2%
886,453
-0.1%
1.20%
+27.1%
Q1 2023$16,695,711
+9.5%
887,126
-7.4%
0.95%
+8.5%
Q4 2022$15,246,393
+77.9%
957,688
+82.8%
0.87%
+75.9%
Q3 2022$8,571,000
+11.9%
523,870
-3.6%
0.50%
+34.3%
Q2 2022$7,658,000
-31.8%
543,528
+17.3%
0.37%
-17.2%
Q1 2022$11,221,000
+4.3%
463,304
+0.5%
0.45%
+17.0%
Q4 2021$10,761,000
+30.4%
461,051
-7.2%
0.38%
+25.2%
Q3 2021$8,251,000
-34.0%
496,757
-3.1%
0.30%
-31.5%
Q2 2021$12,509,000
-15.5%
512,882
-10.6%
0.44%
-7.9%
Q1 2021$14,808,000
+1.0%
573,936
+109.3%
0.48%
-6.4%
Q4 2020$14,657,000
+29.2%
274,159
-0.3%
0.52%
+12.9%
Q3 2020$11,343,000
+21.9%
274,979
+43.2%
0.46%
+14.5%
Q2 2020$9,304,000
+12.3%
191,958
-2.1%
0.40%
-13.8%
Q1 2020$8,285,000196,0950.46%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 432,317$11,154,0004.70%
Baker Brothers Advisors 41,910,704$1,081,296,0004.69%
Palo Alto Investors LP 2,337,877$60,317,0003.44%
Birchview Capital, LP 177,000$4,567,0002.71%
Longitude (Cayman) Ltd. 188,000$4,850,0001.86%
GREAT POINT PARTNERS LLC 311,217$8,029,0001.66%
Avoro Capital Advisors LLC 2,500,000$64,500,0001.11%
PFM Health Sciences, LP 1,302,129$33,595,0001.03%
HealthCor Management, L.P. 900,490$23,233,0000.82%
Eversept Partners, LP 420,000$10,836,0000.82%
View complete list of ACADIA PHARMACEUTICALS INC shareholders